FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

29507611000001101: Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-May 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
92499501000001115 Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92499601000001116 Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Is a Ruxolitinib 10mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has AMP Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Ruxolitinib phosphate false Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Ruxolitinib phosphate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start